Westfield Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-100,981
| Closed | -$8.18M | – | 250 |
|
|
2023
Q4 | $8.18M | Buy |
100,981
+2,093
| +2% | +$170K | 0.05% | 193 |
|
|
2023
Q3 | $7.41M | Buy |
98,888
+6,137
| +7% | +$460K | 0.05% | 183 |
|
|
2023
Q2 | $7.15M | Buy |
92,751
+5,991
| +7% | +$462K | 0.05% | 184 |
|
|
2023
Q1 | $7.2M | Buy |
86,760
+3,165
| +4% | +$263K | 0.05% | 187 |
|
|
2022
Q4 | $7.18M | Buy |
83,595
+4,666
| +6% | +$401K | 0.06% | 183 |
|
|
2022
Q3 | $4.87M | Sell |
78,929
-2,326
| -3% | -$143K | 0.04% | 195 |
|
|
2022
Q2 | $5.02M | Buy |
+81,255
| New | +$5.02M | 0.04% | 199 |
|
|
2017
Q2 | – | Sell |
-45,465
| Closed | -$3.09M | – | 263 |
|
|
2017
Q1 | $3.09M | Sell |
45,465
-1,356,514
| -97% | -$92.1M | 0.03% | 235 |
|
|
2016
Q4 | $100M | Sell |
1,401,979
-130,839
| -9% | -$9.37M | 0.88% | 27 |
|
|
2016
Q3 | $121M | Buy |
+1,532,818
| New | +$121M | 0.98% | 24 |
|